[Form 4] DXP Enterprises Inc Insider Trading Activity

Rhea-AI Filing Summary

DXP Enterprises Inc. (DXPE) filed a Form 4 disclosing that director Karen Hoffman received a grant of 917 shares of common stock on 1 July 2025. The shares were recorded at an acquisition price of $90.04 and will fully vest one year from the grant date, per the filing’s footnote. Following the transaction, Hoffman’s direct ownership increased to 7,186 shares. No derivative transactions were reported and the filing was made individually by the director.

Insights

Securities Analyst

TL;DR: Small insider grant; signals alignment but immaterial to valuation.

The reported transaction is a routine director equity grant totaling roughly $82k (917 shares × $90.04). While insider acquisitions can indicate confidence, the position size is modest relative to DXPE’s market capitalization and trading volume. No open-market purchase, sale, or option exercise occurred, and there is no change in control or governance. Consequently, the disclosure is neutral for valuation and liquidity, though it marginally strengthens director-shareholder alignment. Impact: Not impactful.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoffman Karen

(Last) (First) (Middle)

5301 HOLLISTER ST

(Street)

HOUSTON TX 77040

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DXP ENTERPRISES INC [ DXPE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
DXP Common Stock	07/01/2025		A		917(1)	A	$90.04	7,186	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The term of the grant provide for full vesting one year from the date of grant. [Grant date July 1, 2025 - 917 shares]

Remarks:

	/s/ Karen Hoffman Morris	07/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DXPE report on Form 4 dated July 7 2025?

DXPE disclosed a grant of 917 shares of common stock to director Karen Hoffman on July 1 2025.

At what price were the shares granted to the DXPE director?

The filing lists an acquisition price of $90.04 per share.

How many DXPE shares does Director Karen Hoffman now own?

After the grant, she directly holds 7,186 shares of DXP Enterprises common stock.

Does the Form 4 include any derivative security transactions for DXPE?

No; the derivative securities section shows no entries.

When will the granted DXPE shares vest?

According to the footnote, the shares fully vest one year from the July 1 2025 grant date.

Is this DXPE Form 4 filing made by more than one reporting person?

No; it is filed solely by Director Karen Hoffman.